SCHEMBL6925075

SCHEMBL6925075

CC(C1CCCCC1)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.49
HTT P42858 2/20 0.49
MAPT P10636 1/20 0.47
PKM P14618 1/20 0.47
HPGD P15428 1/20 0.47
ALOX15 P16050 1/20 0.47
ALOX12 P18054 1/20 0.47
MC4R P32245 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 1/20 0.44
TSHR P16473 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CYP2C19 P33261 1/20 0.43
DPP4 P27487 1/20 0.43
NR1H2 P55055 1/20 0.43
NR1H3 Q13133 1/20 0.43
OPRM1 P35372 1/20 0.43
OPRK1 P41145 1/20 0.43
OPRL1 P41146 1/20 0.43
PTPN1 P18031 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6925072 1.00 ALDH1A1 (0.49) ALDH1A1HTTMAPTPKMHPGD
SCHEMBL6789647 0.85 TDP1 (0.42) ALDH1A1HTTMAPTALOX15TDP1
Hydrochloric Acid SCHEMBL27657147 0.81 HTR2B (0.40) ALDH1A1HTTTDP1LMNACASP3
SCHEMBL28504657 0.79 CYP1B1 (0.59) ALDH1A1MAPTL3MBTL1LMNAKMT2A
SCHEMBL28507217 0.79 CYP1B1 (0.59) ALDH1A1MAPTL3MBTL1LMNAKMT2A
SCHEMBL6881201 0.79 HTR3E (0.42) ALDH1A1HTTMAPTTDP1TSHR
SCHEMBL14928513 0.78 ALDH1A1 (0.44) ALDH1A1HTTMAPTPKMHPGD
SCHEMBL5139365 0.78 ALDH1A1 (0.44) ALDH1A1HTTMAPTPKMHPGD
SCHEMBL5601974 0.76 TDP1 (0.51) ALDH1A1HTTMAPTPKMHPGD
SCHEMBL5600097 0.76 TDP1 (0.51) ALDH1A1HTTMAPTPKMHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6515129-B1 A pharmaceutical composition which comprises, a cyclic imide derivative represented by the general formula (I): present invention relates to an aminopeptidase N inhibitor or an angiogenesis inhibitor, modulates production of tumor necrosis ISHIHARA SANGYO KAISHA LTD. (JP) 2003-02-04 US disclosed
US-6429212-B1 AMINOPEPTIDASE N INHIBITOR USED TO TREAT CANCER, TUMORS, AND RETINOPATHY; FEW SIDE EFFECTS; ANGIOGENESIS INHIBITOR ISHIHARA SANGYO KAISHA LTD. (JP) 2002-08-06 US disclosed